uniQure QURE
NASDAQ QURE
$38.32 -4.44 (-10.38%)
At close: Sep 24, 2026 · 4:00 PM EDT

uniQure (QURE) Cash from Operations (2016 - 2026)

uniQure (QURE) posted Cash from Operations of -$28.6 million for Q2 2026, up 25.28% on a QoQ basis from -$38.2 million in Q1 2026, and up 28.37% year-over-year from -$22.3 million in Q2 2025.

Analysis

uniQure (QURE) Cash from Operations (2016 - 2026) Analysis & Trends

uniQure has reported Cash from Operations for 11 years, with the latest figure at -$28.6 million in Q2 2026.

  • On a quarterly basis, Cash from Operations rose 28.37% year-over-year to -$28.6 million in Q2 2026; TTM through Jun 2026 was -$160.8 million, a 7.29% increase from a year earlier, with the FY2025 full-year figure at -$178.0 million, up 2.61% from the prior year.
  • Cash from Operations was -$28.6 million for Q2 2026 at uniQure, up from -$38.2 million in the prior quarter.
  • The five-year high for Cash from Operations was $38.9 million in Q3 2023, with the low at -$78.3 million in Q1 2023.
  • Average Cash from Operations over 5 years is -$39.9 million, with a median of -$42.0 million recorded in 2025.
  • The largest YoY upside for Cash from Operations was 179.42% in 2023 against a maximum downside of 263.55% in 2023.
  • Over 5 years, Cash from Operations stood at -$54.7 million in 2022, then gained by 9.4% to -$49.5 million in 2023, then retreated by 6.67% to -$52.8 million in 2024, then sank by 46.79% to -$77.6 million in 2025, then jumped by 63.16% to -$28.6 million in 2026.
  • The last three Cash from Operations figures came in at -$28.6 million (Q2 2026), -$38.2 million (Q1 2026), and -$77.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 8.62 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 3.44 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn 5.37 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 5.88 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn 2.87 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 4.00 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn 3.57 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn 835.00 Mn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 1.13 Bn
10 uniQure 2.96 Bn 2.96 Bn 5.49 Mn -28.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -28.58 Mn
Mar 31, 2026 -38.24 Mn
Dec 31, 2025 -77.57 Mn
Sep 30, 2025 -16.40 Mn
Jun 30, 2025 -39.90 Mn
Mar 31, 2025 -44.10 Mn
Dec 31, 2024 -52.84 Mn
Sep 30, 2024 -36.60 Mn
Jun 30, 2024 -32.71 Mn
Mar 31, 2024 -60.58 Mn
Dec 31, 2023 -49.54 Mn
Sep 30, 2023 38.91 Mn
Jun 30, 2023 -57.00 Mn
Mar 31, 2023 -78.30 Mn
Dec 31, 2022 -54.68 Mn
Sep 30, 2022 -48.99 Mn
Jun 30, 2022 -15.68 Mn
Mar 31, 2022 -25.71 Mn
Dec 31, 2021 -47.09 Mn
Sep 30, 2021 -40.16 Mn
API Access

uniQure Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=QURE&period=max&api_key=YOUR_API_KEY